Absorption of cyclosporine neoral early after liver transplantation: Is it possible to abandon intravenous cyclosporine A application?

Transplantation Proceedings

Volumn 28, Issue 4, 1996, Pages 2239-2240

  Haller, G W ^a   Winkler, M ^a   Bechstein, W O ^a   Oldhafer, K J ^a   Ringe, B ^a   Maibucher, A ^a   Farber, L ^a   Pichlmayr, R ^a   Neuhaus, P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR ANTIBODY; LYMPHOCYTE ANTIBODY; STEROID; THYMOCYTE ANTIBODY;

ADULT; ANXIETY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG HALF LIFE; ENTERIC FEEDING; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPERTENSION; HYPERTRICHOSIS; INSOMNIA; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; MALE; NEPHROTOXICITY; NERVOUSNESS; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PARESTHESIA; PRIORITY JOURNAL; TREMOR;

ADMINISTRATION, ORAL; ADULT; CYCLOSPORINE; DOSAGE FORMS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; INTESTINAL ABSORPTION; LIVER TRANSPLANTATION; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; TIME FACTORS;

EID: 0029838984     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)